Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Immunotherapy Advances|December 25, 2025
A phase 1 experimental medicine study of anti-CD3 monoclonal antibody in rheumatoid arthritisCatherine A Lawson, Rachel Harry, Bridget Griffiths, et al.BMJ Open Gastroenterology|January 27, 2023
Pancreaticobiliary versus head and neck presentation of immunoglobulin G4-related disease: different sides of the same coin?Bidour Awadelkarim, Josephine Vila, Manu K Nayar, et al.Rheumatology (Oxford, England)|June 28, 2015
Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosisMichael Hughes, Voon H Ong, Marina E Anderson, et al.Clinical Medicine (London, England)|May 7, 2020
Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemicElizabeth Price, Elizabeth MacPhie, Lesley Kay, et al.Annals of the Rheumatic Diseases|December 11, 2012
Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factorsMarzena Ciechomska, Christiaan A Huigens, Thomas Hügle, et al.The Journal of Rheumatology|November 5, 2002
Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: influence of reading with or without known sequenceKarin Bruynesteyn, Désirée Van Der Heijde, Maarten Boers, et al.Arthritis and Rheumatism|April 16, 2002
Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable differenceKarin Bruynesteyn, Désirée van der Heijde, Maarten Boers, et al.Rheumatology Advances in Practice|March 12, 2024
Differences in management approaches for lupus nephritis within the UKSara T Ibrahim, Christopher J Edwards, Michael R Ehrenstein, et al.Arthritis and Rheumatism|August 1, 2007
Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosusKathleen McElhone, Janice Abbott, Joanna Shelmerdine, et al.The Journal of Rheumatology|September 3, 2010
The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosusKathleen McElhone, Madhura Castelino, Janice Abbott, et al.Pageof 7